Bruce Jackson
Stock Analyst at Benchmark
(1.09)
# 2,940
Out of 4,667 analysts
111
Total ratings
28.57%
Success rate
-17.15%
Average return
Main Sectors:
Stocks Rated by Bruce Jackson
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BFRI Biofrontera | Reiterates: Buy | $7 | $0.77 | +810.87% | 7 | Nov 15, 2024 | |
| EXAS Exact Sciences | Maintains: Buy | $67 → $65 | $53.92 | +20.55% | 6 | Nov 6, 2024 | |
| HOTH Hoth Therapeutics | Reiterates: Speculative Buy | $3 | $0.82 | +266.75% | 3 | Oct 11, 2024 | |
| MLSS Milestone Scientific | Initiates: Speculative Buy | $1.25 | $0.63 | +99.98% | 1 | Oct 10, 2024 | |
| HUMA Humacyte | Reiterates: Buy | $15 | $4.42 | +239.37% | 12 | Oct 10, 2024 | |
| GDTC CytoMed Therapeutics | Reiterates: Speculative Buy | $5 | $2.01 | +148.83% | 4 | Oct 10, 2024 | |
| NEO NeoGenomics | Reiterates: Buy | $18 | $15.36 | +17.19% | 6 | Sep 24, 2024 | |
| UNCY Unicycive Therapeutics | Reiterates: Speculative Buy | $3 | $0.49 | +518.56% | 7 | Sep 6, 2024 | |
| MOVE Movano | Reiterates: Speculative Buy | $30 | $3.08 | +873.33% | 2 | Sep 4, 2024 | |
| CDIO Cardio Diagnostics Holdings | Reiterates: Speculative Buy | $2 | $0.26 | +669.53% | 5 | Aug 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Speculative Buy | $17 | $1.26 | +1,249.21% | 4 | Aug 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | n/a | $0.67 | - | 2 | Aug 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Speculative Buy | $24 | $2.54 | +844.88% | 3 | Aug 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $57 | $82.34 | -30.77% | 7 | Aug 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Speculative Buy | $25 | $2.48 | +908.06% | 6 | Jun 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Speculative Buy | $1 | $0.23 | +327.90% | 2 | May 29, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $100 | $4.66 | +2,045.92% | 6 | May 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Speculative Buy | $5 | $2.55 | +96.08% | 5 | Apr 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Speculative Buy | $5 | $2.10 | +138.10% | 4 | Mar 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $1.62 | - | 7 | Nov 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $26.14 | - | 7 | Sep 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Speculative Buy | $7 | $2.05 | +241.46% | 4 | Jun 22, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Speculative Buy | $800 | $2.64 | +30,203.03% | 1 | Aug 8, 2022 |
Biofrontera
Nov 15, 2024
Reiterates: Buy
Price Target: $7
Current: $0.77
Upside: +810.87%
Exact Sciences
Nov 6, 2024
Maintains: Buy
Price Target: $67 → $65
Current: $53.92
Upside: +20.55%
Hoth Therapeutics
Oct 11, 2024
Reiterates: Speculative Buy
Price Target: $3
Current: $0.82
Upside: +266.75%
Milestone Scientific
Oct 10, 2024
Initiates: Speculative Buy
Price Target: $1.25
Current: $0.63
Upside: +99.98%
Humacyte
Oct 10, 2024
Reiterates: Buy
Price Target: $15
Current: $4.42
Upside: +239.37%
CytoMed Therapeutics
Oct 10, 2024
Reiterates: Speculative Buy
Price Target: $5
Current: $2.01
Upside: +148.83%
NeoGenomics
Sep 24, 2024
Reiterates: Buy
Price Target: $18
Current: $15.36
Upside: +17.19%
Unicycive Therapeutics
Sep 6, 2024
Reiterates: Speculative Buy
Price Target: $3
Current: $0.49
Upside: +518.56%
Movano
Sep 4, 2024
Reiterates: Speculative Buy
Price Target: $30
Current: $3.08
Upside: +873.33%
Cardio Diagnostics Holdings
Aug 27, 2024
Reiterates: Speculative Buy
Price Target: $2
Current: $0.26
Upside: +669.53%
Aug 26, 2024
Reiterates: Speculative Buy
Price Target: $17
Current: $1.26
Upside: +1,249.21%
Aug 16, 2024
Reiterates: Hold
Price Target: n/a
Current: $0.67
Upside: -
Aug 14, 2024
Reiterates: Speculative Buy
Price Target: $24
Current: $2.54
Upside: +844.88%
Aug 13, 2024
Reiterates: Buy
Price Target: $57
Current: $82.34
Upside: -30.77%
Jun 3, 2024
Reiterates: Speculative Buy
Price Target: $25
Current: $2.48
Upside: +908.06%
May 29, 2024
Reiterates: Speculative Buy
Price Target: $1
Current: $0.23
Upside: +327.90%
May 23, 2024
Reiterates: Buy
Price Target: $100
Current: $4.66
Upside: +2,045.92%
Apr 15, 2024
Reiterates: Speculative Buy
Price Target: $5
Current: $2.55
Upside: +96.08%
Mar 21, 2024
Reiterates: Speculative Buy
Price Target: $5
Current: $2.10
Upside: +138.10%
Nov 14, 2023
Downgrades: Hold
Price Target: n/a
Current: $1.62
Upside: -
Sep 15, 2023
Downgrades: Hold
Price Target: n/a
Current: $26.14
Upside: -
Jun 22, 2023
Reiterates: Speculative Buy
Price Target: $7
Current: $2.05
Upside: +241.46%
Aug 8, 2022
Initiates: Speculative Buy
Price Target: $800
Current: $2.64
Upside: +30,203.03%